Literature DB >> 15608686

hTERT antagonizes p53-induced apoptosis independently of telomerase activity.

Rubaiyat Rahman1, Leena Latonen, Klas G Wiman.   

Abstract

The p53 tumor suppressor controls cell growth and survival through transcriptional regulation of gene expression. Previously, we found that the human telomerase reverse transcriptase (hTERT) gene is downregulated by p53. To investigate if hTERT downregulation has a role in p53-dependent apoptosis, we tested if constitutive expression of telomerase could inhibit p53-induced apoptosis. Here we show that constitutive hTERT expression results in increased survival following activation of exogenous temperature-sensitive p53 in BL41 Burkitt lymphoma cells. Similarly, constitutive hTERT expression inhibited wild-type p53-dependent apoptosis in response to mitomycin C or 5-fluorouracil in HCT116 colon carcinoma cells carrying endogenous p53. A telomerase-inactive hTERT mutant was equally efficient in antagonizing p53-induced apoptosis. These findings support the notion that hTERT has antiapoptotic activity and demonstrate that p53-mediated downregulation of hTERT is critical for efficient p53-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608686     DOI: 10.1038/sj.onc.1208232

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

Review 1.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

2.  Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes.

Authors:  Wentao Dai; Huajie Chen; Rian Yu; Lingfei He; Bing Chen; Xuemin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  p53 targets identified by protein expression profiling.

Authors:  Rubaiyat Rahman-Roblick; Uwe Johannes Roblick; Ulf Hellman; Paolo Conrotto; Tao Liu; Susanne Becker; Daniel Hirschberg; Hans Jörnvall; Gert Auer; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Progression of astrocytomas and meningiomas: an evaluation in vitro.

Authors:  L Maes; J P O Kalala; M Cornelissen; L de Ridder
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

5.  Telomerase is involved in IL-7-mediated differential survival of naive and memory CD4+ T cells.

Authors:  Yinhua Yang; Jie An; Nan-ping Weng
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

6.  Transcriptional regulation of the human telomerase reverse transcriptase: new insights.

Authors:  Amel Chebel; Martine Ffrench
Journal:  Transcription       Date:  2010 Jul-Aug

7.  Saccharomyces cerevisiae as a model for the study of extranuclear functions of mammalian telomerase.

Authors:  Lucia Simonicova; Henrieta Dudekova; Jaroslav Ferenc; Katarina Prochazkova; Martina Nebohacova; Roman Dusinsky; Jozef Nosek; Lubomir Tomaska
Journal:  Curr Genet       Date:  2015-01-08       Impact factor: 3.886

8.  An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells.

Authors:  Imke Listerman; Francesca S Gazzaniga; Elizabeth H Blackburn
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

9.  The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.

Authors:  Imke Listerman; Jie Sun; Francesca S Gazzaniga; Jason L Lukas; Elizabeth H Blackburn
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

10.  Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase.

Authors:  Sofia L Vidal-Cardenas; Carol W Greider
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.